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The metabolic profiles of HIV-infected and  
non-infected women in Mangaung, South Africa
Introduction
Human Immunodeficiency Virus (HIV) infection has reached epidemic 
proportions in South Africa, where increasing numbers of people 
now die because of Acquired Immune Deficiency Syndrome (AIDS).1 
Malnutrition remains a significant but intriguing consequence 
of HIV infection.2 Besides factors such as decreased food intake 
and malabsorption, HIV infection is typically associated with 
adverse metabolic events.3 Abnormalities in protein, glucose and 
lipid metabolism have been evident in HIV infected patients since 
recognition of the AIDS epidemic (reviewed by Salas-Salvadó and 
Garcia-Lorda).4 Although there is consensus that major nutritional 
changes are rare in clinically stable HIV-infected populations,5 
alterations in the biochemical nutritional status of asymptomatic 
HIV-infected black people have been documented.6 Factors such as 
HIV, opportunistic infections and the host’s immune response to the 
disease can affect metabolic changes directly or indirectly. However, 
questions regarding metabolism in HIV infection remain a puzzle, 
and the causes thereof should be determined.4
Until the end of 2003, when the South African government initiated 
its long-awaited “Operational plan for Comprehensive HIV and AIDS 
Care, Management and Treatment for South Africa”, antiretroviral 
therapy (ART) could only be afforded by a few privileged South 
Africans living with this disease. With the approval of this plan, the 
South African government committed itself to provide free ART, 
which is, however, currently restricted to AIDS patients with CD4+ 
cell counts ≤ 200 mm3.7 Current studies conducted on individuals 
with HIV infection and AIDS mainly focus on the effect of ART on the 
metabolic profile of patients using this medication. In South Africa, 
literature on the metabolic effect of HIV infection in ART-naive black 
people is limited. 
In this article, the authors provide information that could lead to 
a better understanding of the effect of HIV infection on metabolic 
profiles in human subjects, with special emphasis on black females 
not on any current treatment for HIV infection.
Abstract
Objective: To determine the biochemical nutritional status of HIV-infected women in Mangaung.  
Design: Cross-sectional.  
Setting: The community of Mangaung, Free State, South Africa.  
Subjects: A representative group of 500 black women (25–44 years) was selected randomly to participate. 
Outcome measures: Biochemical analyses were performed for total lymphocytes, serum protein, serum albumin, plasma fibrinogen, 
serum insulin, serum glucose, serum triglycerides and serum cholesterol using standard methodology. Values were compared to standard 
references, and between HIV-infected and HIV-uninfected women.  
Results: After screening for eligibility, 488 women qualified. Sixty-one per cent of the younger women (25–34 years) and 38% of the older 
women (35–44 years) were HIV-infected. HIV-infected women had significantly lower median blood values for total lymphocytes (p = 
0.0001 and p = 0.02 for younger and older group respectively) and serum albumin (p = 0.0001 for both age groups), but significantly higher 
median concentrations of serum protein (p = 0.0001 for both age groups) than uninfected women. Plasma fibrinogen and serum insulin 
concentrations were significantly lower in HIV-infected younger women than in their uninfected counterparts (p = 0.002 for both parameters). 
Older HIV-infected women had significantly lower total serum cholesterol values (p = 0.01) than older HIV-uninfected women. Serum glucose 
and serum triglycerides did not differ significantly between HIV-infected and HIV-uninfected women.  
Conclusions: The results indicate a possible impact of HIV infection on serum protein and serum albumin, which may adversely affect 
biochemical nutritional status and the course of HIV progression. Future research into the causes and possible treatment of metabolic 
changes in women in this community should be prioritised.
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Methodology
A representative sample of 500 women from two formal settlements 
(Phahameng and Botchabela) and two informal settlements (Joe 
Slovo and Namibia) from the existing 13 sites in Mangaung, the 
black residential township of Bloemfontein, was randomly selected 
to participate, using township maps. The four sites were considered 
to be representative of the Mangaung area. The residential plots in 
the four selected areas were counted and numbered. Namibia had 
2 995 plots, Pahameng 1 711, Joe Slovo 1 359 and Botchabela 
2 308. Non-pregnant, pre-menopausal, but post-pubertal women 
between the age of 25 and 44 years were targeted to participate. 
The sampling strategy was designed specifically to compare 
(as part of the larger study) the two age categories to render the 
study results comparable with those of another study in the same 
geographical area.8 A proportionate number of respondents (180 
from Namibia, 100 from Pahameng, 80 from Joe Slovo and 140 from 
Botchabela) was randomly selected from these settlements. Twenty 
subjects were recruited per week over a 25-week period (March 
2000 – November 2000). A randomly selected residential plot was 
approached by a community health care worker who received prior 
training in obtaining informed consent and explaining the purpose 
and procedures of the study to possible participants. One woman per 
selected residential plot was screened for eligibility (not pregnant 
and within the age group). If no one was at home, the residential plot 
to the right was targeted and if still unsuccessful, the residential plot 
to the left of the original address was approached. If these attempts 
failed, another residential plot was randomly selected. The assigned 
community health workers explained the purpose of the study to 
possible participants. The women took part voluntarily, after giving 
written informed consent. The study was approved by the Ethics 
Committee of the Faculty of Health Sciences, University of the Free 
State (ETOVS no. 02/00). All participants were originally unaware 
of their HIV-status, and therefore not receiving any antiretroviral 
medication. Subjects could indicate whether they would like to 
receive their HIV test results or not. Those preferring to be informed 
of their HIV status (< 30% of total sample) were confidentially 
seen by a medical practitioner, who referred HIV-infected patients 
for counselling and further follow-up. The research team was kept 
blinded to the outcome of the individual HIV tests.
Laboratory determinations were done for HIV status, total lymphocytes, 
total serum protein, serum albumin, plasma fibrinogen, serum insulin, 
serum glucose, serum triglycerides and total serum cholesterol 
at the Fibrinogen Unit, Central University of Technology, Free State. 
Respondents fasted overnight, abstained from exercise and avoided 
consuming alcohol and caffeine for 24 hours prior to the collection 
of the blood samples. All blood samples were taken in the morning. 
Not all samples could be evaluated due to clotting or haemolysis. The 
number of samples that could not be used was very low and did not 
result in bias. Respondents were not requested to return for repeat 
samples. See Box 1 for the methods and equipment used.
Statistical analysis
Data was processed using the SAS software program.10 All datasets 
were categorised into two age groups (25–34 years, and 35–44 
years), and two HIV status groups (HIV-uninfected and HIV-infected). 
For each group, continuous variables were described by medians, 
and categorical variables were described by frequencies and 
percentages. The significance of the median difference between 
laboratory blood values of younger and older HIV-uninfected and 
HIV-infected women was determined by 95% non-parametric 
confidence intervals (CI) and the Mann-Whitney test. P values ≤ 0.05 
were considered statistically significant.
Results
Of the original sample of 500, 488 subjects met the inclusion criteria. 
Of these subjects, 273 were 25 to 34 years and 215 were 35 to 
44 years old. In the respondents that were 25 to 34 years old, 167 
of the 273 (61%), and in the age group 35 to 44 years, 82 of the 
215 (38%) were HIV infected. Twelve respondents were excluded 
from the study: four were found to be pregnant during the medical 
examination, and eight did not meet the age requirement.
Table I illustrates the descriptive biochemical parameters of HIV-
infected and HIV-uninfected women (25–34 years and 35–44 years). 
On average all parameters were within the normal reference ranges, 
except for serum total protein, which was elevated in the HIV-
infected group (both age groups). The median serum total protein 
was statistically significantly higher in HIV-infected women than in 
uninfected women (p = 0.0001 for both age groups). In contrast, 
the median serum albumin was statistically significantly lower in 
HIV-infected women than in uninfected women (p = 0.0001 for both 
age groups).
Box 1: Methods and equipment used
Parameter Methods and equipment
HIV tests Human Immunodeficiency Viruses (HIV 1/HIV-2: 
Recombinant antigens and synthetic peptides) 
reagent pack (Abbott, Germany, catalogue no  
3D41-20)
Total lymphocyte counts Via a full blood count on ethyldimethylacetic acid 
(EDTA) blood using a Coulter Microdiff 18 Cell  
Counter
Total serum protein Colorimetric method using Boehringer Mannheim-
Roche Diagnostics, Mannheim, Germany (catalogue 
no 1553836) 
Total serum albumin Colorimetric method using Roche Diagnostics  
GmbH, Mannheim, Germany (catalogue no 1970569) 
Plasma fibrinogen 
concentration
The method of Clauss9 for a quantitative 
determination
Serum glucose Enzymatic colorimetric method using Roche 
Diagnostics GmbH, Mannheim, Germany (catalogue 
no 1448668)
Serum insulin DRG insulin ELISA
Fasting triglycerides GPO-PAP method using Roche Diagnostics GmbH, 
Mannheim, Germany (catalogue no. 148872) based 
on an enzymatic colorimetric principle
Total serum cholesterol CHOD-PAP method using Roche Diagnostics GmbH, 
Mannheim, Germany (catalogue no 1489232) based 
on an enzymatic colorimetric principle
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Apart from serum insulin, all other parameters had on average a 
similar pattern in the two age groups when comparing HIV-infected 
and uninfected women. Total lymphocytes, serum albumin, plasma 
fibrinogen, serum glucose and total cholesterol decreased in the HIV-
infected group, whereas serum triglycerides and serum total protein 
increased in the infected group. The difference was significant for 
total lymphocytes (p = 0.0001 and 0.02 in young and older group 
respectively) and plasma fibrinogen in the younger group (p = 0.002) 
and for total cholesterol in the older group (p = 0.01). The pattern 
in median serum insulin differed between the two age groups 
comparing infected and uninfected women. In the younger group 
the serum insulin was significantly lower (p = 0.002) in the infected 
group, whereas it was elevated in the older infected group (although 
not significantly so) (Table I).
Although most parameters were within the normal reference ranges, 
it is evident that many women in both age groups and HIV status 
groups had laboratory values outside these ranges (Tables II and III). 
As also reflected by the average parameter values, a similar pattern 
in the two age groups (when comparing HIV-infected and uninfected 
women) was seen for all parameters, except for serum insulin.
Table I: Descriptive biochemical parameters of HIV-infected and HIV-uninfected women (25–34 years and 35–44 years)















Total lymphocytes  
(x 109/L)
2.4 2.1 *0.0001 0.4; [0.2; 0.5] 2.2 2.0 *0.02 0.2; [0.0; 0.4]
N 104 158 130 80
Serum total protein (g/L) 82 91 *0.0001 -7; [-10; -5] 82 91.5 *0.0001 -9; [-11; -6]
N 106 167 132 82
Serum albumin (g/L) 42.9 40.2 *0.0001 2.6; [1.5; 3.7] 42.2 39.6 *0.0001 2.7 [1.7; 3.7]
N 106 167 131 82
Plasma fibrinogen (g/L) 3.6 3.2 *0.002 0.33; [0.13; 0.56] 3.4 3.2 0.18 -0.17; [-0.44; 0.08]
N 100 157 127 76
Serum glucose (mmol/L) 4.4 4.3 0.26 -0.11; [-0.30; 0.08] 4.4 4.3 1.0 0 [-0.21; 0.22]
N 105 167 133 82
Serum insulin (μU/ml) 9.1 5.8 *0.002 2.4; [1.0; 4.0] 5.8 6.3 0.17 -61.85; [-171.03; 34.52]
N 106 166 133 82
Triglycerides (mmol/L) 0.90 1.0 0.69 0.02; [-0.08; 0.12] 1.10 1.21 0.42 0.05; [-0.08; 0.19]
N 106 167 132 82
Total cholesterol 
(mmol/L)
4.3 4.1 0.30 -0.01; [-0.04; 0.1] 4.7 4.3 *0.01 0.4; [0.1; 0.7]
N 106 167 132 82
* Significant difference 
Table II: Frequency and percentage of HIV-infected and HIV-uninfected younger women (25–34 years) with reduced, normal and elevated biochemical parameters
Parameter HIV-uninfected HIV-infected 
Reduced Normal Increased Reduced Normal Increased
n % n % N % n % n % n % Normal value
Total lymphocytes 0 0 94 90.4 10 9.6 0 0 145 91.8 13 8.2 0.8–3.3 x 109/L
Serum total protein 0 0 54 50.9 52 49.1 0 0 34 20.4 133 79.6 60–82 g/L
Serum albumin 0 0 90 84.9 16 15.1 14 8.4 134 80.2 19 11.4 34 < 48 g/L
Plasma fibrinogen 0 0 73 73.0 27 27.0 3 1.9 126 80.6 28 17.8 1.5–4 g/L
Serum glucose 7 6.7 84 80.0 14 13.3 8 4.8 144 86.2 15 9.0 3.05–6.38 mmol/L
Serum insulin 5 4.7 82 77.4 19 17.9 33 19.9 120 72.3 13 7.8 2–25 (μU/ml)
Serum triglycerides 0 0 100 94.3 6 5.7 0 0 157 94.0 10 6.0 < 2 mmol/L
Total serum cholesterol 0 0 83 78.3 23 21.7 0 0 135 80.8 32 19.2 > 0.9 < 5.2 mmol/L
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Although the median serum protein in HIV-uninfected women was 
within the normal reference range for both age groups, approximately 
49% of uninfected women in both age groups had serum total protein 
values above the normal reference range. The percentage of HIV-
infected women with elevated serum total protein values was 79.6% 
and 74.4% in the younger and older age groups respectively.
Of the HIV-infected younger women, only 11.4%, and of the HIV-
infected older women, only 2.4% had elevated serum albumin levels. 
The percentage of women with normal serum lymphocyte counts was 
almost the same in HIV-infected and uninfected women in both age 
groups (90.4% and 91.8% respectively of younger HIV-uninfected 
and infected women; 93.1% and 93.8% respectively of older HIV-
uninfected and infected women). Less than 10% of all women had 
elevated lymphocyte counts and only 2.5% of older HIV-infected 
women had decreased total lymphocyte levels (Tables II and III).  
Discussion
In this cross-sectional study, the metabolic status of both HIV-
infected and HIV-uninfected black women was determined, and the 
observed blood values were compared with normal values. Although 
the original study was designed to investigate the prevalence of 
diseases of lifestyle in urbanised black women in Mangaung, the 
unexpected high prevalence of HIV infection necessitated the 
determination of the relationship between HIV status and selected 
metabolic parameters.
Some researchers reported no significant changes in lymphocyte 
count in HIV asymptomatic subjects during a follow-up period of 
15 months. However, patients with more advanced disease showed 
significantly reduced total lymphocyte counts over a period of five 
months.11 When men and women during all stages of HIV infection 
were investigated, no significant differences in absolute lymphocyte 
counts were found between patients with stable weight and those 
who had lost weight.12 In the younger group in the present study 
(with the higher prevalence of HIV infection) there was no evidence 
of lymphocyte depletion in the infected women. This might be due to 
a shorter duration of infection and an early stage of the disease. In 
the older group, the majority of infected women did not suffer from 
lymphocyte depletion, with a very small percentage of HIV-infected 
women demonstrating low lymphocyte counts. The extent of this 
reduction is not known and therefore no correlation between disease 
progression and the lymphocyte values can be speculated upon.  
Studies reviewed by Gramlich and Mascioli13 indicated elevated total 
protein and normal or reduced serum albumin levels in asymptomatic 
HIV-infected and AIDS patients. Significantly higher total serum 
protein levels between asymptomatic HIV-infected and uninfected 
black South Africans have also been reported.6 Notwithstanding 
significantly lower albumin concentrations in the HIV-infected 
subjects in that study, albumin levels were still high. Furthermore, 
anthropometric indices and nutrient intake between HIV-infected and 
uninfected subjects did not differ significantly. The authors therefore 
suggested a possible decrease in nutritional status. Asymptomatic 
HIV-infected subjects who followed a diet rich in animal foods also 
reflected smaller decreases in serum albumin and lipid variables.6 
It has been suggested that factors such as infection, changes in 
vascular permeability and hydration status can affect circulating 
proteins,13 including total protein. During infection, the acute-phase 
response is rapidly harnessed to eliminate microbes, control further 
damage, clear infectious debris, and initiate repair processes.14 These 
factors could possibly have contributed to elevated serum protein 
levels in the present study, where median values of total serum protein 
of both groups of HIV infected women were significantly higher than 
the levels in their uninfected counterparts (Table I). The elevated total 
protein levels in 49.1% of the younger HIV- uninfected women and 
in 49.2% of the older HIV-uninfected women may be attributed to 
other infections that need further investigation. However, it is also 
known that black people have significantly higher immuno-globulin 
G levels than white people,15 and this could be a contributing factor 
to the elevated levels in the HIV-uninfected group. The differences 
between the infected and uninfected groups (both age groups) were 
significant and HIV infection is probably the main reason.  
Table III: Frequency and percentage of HIV-infected and HIV-uninfected older women (35–44 years) with reduced, normal and elevated biochemical parameters
Parameter HIV-uninfected HIV-infected
Reduced Normal Increased Reduced Normal Increased
n % n % n % n % n % n % Normal value
Total lymphocytes 0 0 121 93.1 9 6.9 2 2.5 75 93.8 3 3.8 0.8–3.3 x 109/L
Serum total protein 0 0 67 50.8 65 49.2 0 0 21 25.6 61 74.4 60–82 g/L
Serum albumin 2 1.5 124 94.7 5 3.8 9 11.0 71 86.6 2 2.4 34 < 48 g/L
Plasma fibrinogen 2 1.6 90 70.9 35 27.6 0 0 61 80.3 15 19.7 1.5–4 g/L
Serum glucose 9 6.8 120 90.2 4 3.0 4 4.9 73 89.0 5 6.1 3.05–6.38 mmol/L
Serum insulin 27 20.3 97 72.9 9 6.8 13 15.9 55 67.1 14 17.1 2–25 (μU/ml)
Serum triglycerides 0 0 116 87.9 16 12.1 0 0 69 84.2 13 15.9 < 2 mmol/L
Total serum cholesterol 0 0 88 66.7 44 33.3 0 0 65 79.3 17 20.7 > 0.9 < 5.2 mmol/L
Original Research: The metabolic profiles of hiv-infected and non-infected women 
27
Original Research: The metabolic profiles of hiv-infected and non-infected women 
2009;22(1)S Afr J Clin Nutr
While some proteins increase as a reaction to the acute-phase 
response, others, such as albumin, decrease in concentration,14 
and have been associated with shorter survival in women with 
HIV infection.16 Most women (infected or not) in both age groups 
had normal serum albumin levels. The 8.4% and 11% of infected 
women (younger and older group respectively) with reduced levels 
of albumin possibly reflect the reaction of the acute-phase response 
to the infection.17 Luder et al12 reported no significant differences 
in albumin levels between HIV-infected or AIDS patients with stable 
weight and those who had lost weight. However, Van Staden et al17 
found significantly lower serum albumin levels between patients 
with CD4 cell counts < 200/mm3 and those with CD4 cell counts of 
200 to 499/mm3. In the uninfected older women, 1.5% had reduced 
levels of albumin. The possibility of other infections at play should 
be investigated.  
Fibrinogen is an acute-phase protein involved in blood clotting. The 
acute-phase response is the primary mechanism used by the body 
to restore homeostasis following infection, and is characterised by 
increased concentrations of circulating fibrinogen.18 In the present 
study, in both age groups, median plasma fibrinogen concentrations 
were lower in HIV-infected women than in HIV-uninfected women (to 
a significant degree in the younger group). This is not due to fibrinogen 
levels in the sub-normal range in HIV-infected women, but rather to 
the larger percentage of uninfected women with elevated fibrinogen 
levels, possibly resulting from a complex interplay of factors such 
as alcohol consumption, smoking, following a less prudent diet and 
physical inactivity.19 In the Transition and Health during Urbanisation 
of South Africans (THUSA) study, fibrinogen concentrations between 
HIV-infected and uninfected subjects did not differ significantly, 
possibly indicating the absence of the acute-phase response in the 
HIV-infected subjects.6 In the HIV-infected group in the present study, 
17.8% and 19.7% and in the HIV-uninfected group 27% and 27.6% 
of the younger and older groups (respectively) had elevated plasma 
fibrinogen levels. Increased plasma fibrinogen levels are associated 
with cardiovascular disease20 and purely based on these levels, 
17.8 % to 27.6% of the women have increased risk of this disease.
Abnormalities in glucose metabolism have been reported before 
treatment with highly active antiretroviral therapy (HAART) became 
the standard of care for HIV patients.  Studies reviewed by Salas-
Salvadó and Garcia-Lorda4 showed that glucose levels may be normal 
or lower than normal, insulin levels may be normal or increased, while 
insulin sensitivity is increased in patients not receiving HAART. In the 
present study, the majority of HIV-infected women (both age groups) 
had normal serum glucose levels and no significant differences were 
detected between HIV infected and uninfected groups. These results 
are similar to those reported for black South Africans6 and support 
the notions that HIV-infected ART-naive individuals may maintain 
normal serum glucose levels (studies reviewed by Salas-Salvadó 
and Garcia-Lorda).4  
In the present study, most women had normal serum insulin levels, 
ranging from 67.1% in the older HIV-infected group to 77.4% in 
the younger HIV-uninfected group.  In the younger group, median 
serum insulin concentrations were significantly lower in the HIV-
infected than in the HIV-uninfected women (Table I). This is probably 
due to the 19.9% of the infected younger women with reduced 
levels of serum insulin and 17.9% of uninfected younger women 
with increased levels. In the older group there was no significant 
difference between the infected and uninfected groups. As the status 
of disease progression in the infected group is unknown, it is difficult 
to come to a conclusion or logical explanation for the differences. 
Some researchers found no differences between insulin levels and 
endogenous glucose production, but significantly lower plasma 
glucose levels in HIV infected men versus controls. The authors 
concluded that HIV-infected men have increased rates of insulin 
clearance and increased sensitivity of peripheral tissues to insulin.21 
In the present study, however, the serum glucose levels in both age 
groups and HIV groups did not differ significantly.
Studies reviewed by Salas-Salvadó4 and Garcia-Lorda and Gramlich 
and Mascioli13 showed that the metabolism of lipids may change 
during HIV infection and AIDS. Total cholesterol levels may be normal 
or reduced, while triglyceride levels may increase. This atypical 
pattern of lipid metabolism has been associated with immune 
impairment and may be a marker of disease progression.22,23 
Decreased cholesterol levels have been previously reported in 
antiretroviral (ARV)-naive HIV infected patients.6,24 Although the 
median total cholesterol in older women was significantly lower 
in the HIV-infected group compared to the HIV-uninfected group 
(Table I), this is most probably due to the fact that 33.3% of the 
uninfected women had elevated levels (compared to the 20.7% 
of the infected group). Nobody in both age groups had decreased 
cholesterol levels. It has been reported that disease stage has a 
lowering effect on cholesterol levels,25 which can occur despite 
stable or increased dietary intakes of saturated fat and cholesterol.22 
This was not evident in the current study, as subjects were possibly 
in an early stage of HIV infection. 
Increased serum triglyceride levels during asymptomatic HIV 
infection have been reported in some studies,23,26 while others do 
not support this notion.22,24 Significantly lower triglyceride levels in 
asymptomatic HIV-infected black men and women than in uninfected 
groups have been documented.6 No significant differences between 
median serum triglyceride levels of HIV uninfected and infected 
women from the two age groups were seen in the present study 
(Table I). Of the older women, 12.1% and 15.9% (HIV-uninfected 
and infected, respectively) fell in the increased risk category of 
elevated serum triglycerides. Smaller percentages were at risk in 
the younger age group. During HIV infection, decreased activity of 
the enzyme lipoprotein lipase can lead to reduced blood clearance 
of triglycerides.27 Increased triglyceride concentrations have been 
reported, even in patients with CD4 cell counts > 400 X 106/l.23 
However, uninfected women in the present study also had elevations 
and other mechanisms are probably at play.
Some changes expected in HIV-infected people were seen in the 
uninfected group (indicating other factors at play). Significant 
differences were observed due to larger percentages of uninfected 
women with values outside the normal reference range than 
infected women. It is therefore not possible to ascribe most of 
these differences to HIV infection based on the data gathered during 
this study.
The results from the present study reinforce the fact that it is of 
paramount importance for the health of all people in South Africa to 
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be aware of their HIV status.  This will enable health care workers to 
make informed and responsible decisions regarding interventions, 
and help governmental institutions to better plan for the health and 
treatment of these people.
Conclusion and recommendations
The results from the study indicate a possible impact of HIV infection 
on serum total protein and serum albumin in ARV-naive persons. For 
all other parameters no evidence could be found to indicate a major 
impact of HIV infection. More information is necessary to correlate 
changes in nutritional parameters to disease status. Future research 
into the causes and possible treatment of metabolic changes in both 
HIV-uninfected and HIV-infected black women in this community 
should be prioritised.
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